Galmed Pharmaceuticals (GLMD) Institutional Ownership $3.05 -0.02 (-0.65%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$808.57K Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024CVI Holdings LLC74,665$25K0.0%-72.3%1.479% 8/15/2023 BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023 BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022 Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022 Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/16/2021 Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% 11/16/2021 Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021 Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% 11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021 Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021 Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021 Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% 8/5/2021 Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868% 7/31/2021 Brave Asset Management Inc.11,470$35K0.0%N/A0.046% 5/19/2021 Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219% 5/17/2021 Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105% 5/14/2021 Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838% 5/13/2021 Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242% 3/26/2021 Susquehanna International Group LLP10,483$33K0.0%N/A0.042% 2/16/2021 Squarepoint Ops LLC21,010$65K0.0%-12.5%0.100% 2/16/2021 Baker BROS. Advisors LP184,927$575K0.0%-10.0%0.876% 2/10/2021 Renaissance Technologies LLC115,800$360K0.0%+238.2%0.548% 2/3/2021 Ibex Investors LLC1,525,000$4.74M1.9%+0.7%7.223% 11/16/2020 Squarepoint Ops LLC24,024$85K0.0%N/A0.114% 11/13/2020 Morgan Stanley130,165$459K0.0%+17.6%0.617% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), CVI Holdings LLC ($25K).Learn more on GLMD's institutional investors. What percentage of Galmed Pharmaceuticals stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which Galmed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M), and CVI Holdings LLC ($194.57K). How much institutional selling is happening at Galmed Pharmaceuticals? Institutional investors have sold a total of 1,844,390 shares in the last 24 months. This volume of shares sold represents approximately $74.82M in transactions. Related Companies ENSC Institutional Ownership SNGX Institutional Ownership COEP Institutional Ownership NLSP Institutional Ownership EYEN Institutional Ownership EVOK Institutional Ownership ADIL Institutional Ownership GRI Institutional Ownership GLTO Institutional Ownership TRIB Institutional Ownership This page (NASDAQ:GLMD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
